Investor and Media Overview
Endo (NASDAQ: ENDP) is a specialty pharmaceutical company committed to helping everyone we serve live their best life through the delivery of quality, life-enhancing therapies. Our decades of proven success come from a global team of passionate employees collaborating to bring the best treatments forward. Together, we boldly transform insights into treatments benefiting those who need them, when they need them.
- February 17, 2021
Events & Presentations
February 26, 2021 at 7:30 AM EST
Q4 2020 Endo International plc Earnings Conference Call
March 1, 2021 at 9:15 AM EST
Endo International plc at the J.P. Morgan 2021 Global High Yield & Leveraged Finance Conference